Sinanović, Osman; Burina, Adnan
January 2006
Pedijatrija Danas: Pediatrics Today;2006, Vol. 2 Issue 1, p28
Academic Journal
Acute disseminated encephalomyelitis (ADEM) is a monophasic, immuno-mediated disease with multifocal demyelinated lesions in the central nervous system (CNS). However, the course of disease could be with multiple sclerosis (MS)-like relapses. ADEM is a childhood disease (children 10 years of age and younger) and could be the first phase of MS in 25% or more children. onset of the disease is acute. The clinical picture depends on the intensity of the process itself, and the parts of the CNS affected. It correlates with an infectious syndrome affecting the menings and different parts of the brain and spinal cord. Prognosis is very uncertain, and the disease is lethal in 1/3 of cases. MS is a chronic inflammatory, non-contagious, progressive multifocal demyelinated, autoimmune disease of the CNS (white matter of the brain and spinal cord) with many and various neurological symptoms. In 85-90% of cases the symptoms come and go in "attacks" (exacerbations and remissions), or slowly progress over time. The cause and pathogenesis of MS still is not well known. Inheritance could have an important possible precipitating role. The pathogenesis of MS includes inflammation, demyelinisation and axonloss. Although demyelinisation could generate relapse, long-term disability is primarily due to irreversible loss of axons and cell death. MS is most frequent in patients 30 to 40 years of age, although it can be seen prior and after this age range. Childhood onset is reported in 3-5% of cases. It is estimated that 2.5% to 5% of all MS patients experience the first MS "attack" before 16 years of age. Onset before the age of 10 occurs in only 0.2% cases. Diagnosis of ADEM and/or MS is based on cerebrospinal liquor analysis, brain evoked potentials (EP's), and magnetic resonance imaging (MRI) of the brain and spinal cord. Computed tomography (CT) of the brain could be useful, not to diagnose MS but to exclude some other brain disorders (tumors, stroke etc.). Recently, for secure diagnose of MS revised McDonald's criteria for MS are used. Patients with ADEM are treated with anti-inflammatory medications (corticosteroids) and immunosuppressive therapy administered in the same manner as in MS. Interferon β (1a, 1b), as well as glatiramer acetate are used to slow the progress of MS.


Related Articles

  • A role for galanin in human and experimental inflammatory demyelination.  // Current Medical Literature: Multiple Sclerosis;2010, Vol. 1 Issue 4, p102 

    The article discusses a study which reveals the increase in galanin expression in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) lesions following ischemic injury in the central nervous system (CNS). The study demonstrates that the manifestation of experimentally induced...

  • Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach. Velez de Mendizabal, Nieves; Hutmacher, Matthew M.; Troconiz, Iñaki F.; Goñi, Joaquín; Villoslada, Pablo; Bagnato, Francesca; Bies, Robert R. // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Background: Relapsing-remitting dynamics are a hallmark of autoimmune diseases such as Multiple Sclerosis (MS). A clinical relapse in MS reflects an acute focal inflammatory event in the central nervous system that affects signal conduction by damaging myelinated axons. Those events are evident...

  • Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica. Neto, Silvio P; Alvarenga, Regina MP; Vasconcelos, Claudia CF; Alvarenga, Marina P; Pinto, Luiz C; Pinto, Vera LR // Multiple Sclerosis Journal;Feb2013, Vol. 19 Issue 2, p173 

    The article presents a study which investigates visual evoked potential (VEP) responses in neuromyelitis optica (NMO) patients. The study used (VEP), which is used in the evaluation of multiple sclerosis (MS) patients,to evaluate 19 NMO patients showing a delay in P100 wave latency with no...

  • Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. Pohl, Daniela; Hennemuth, Isabell; Von Kries, Rüdiger; Hanefeld, Folker; von Kries, Rüdiger // European Journal of Pediatrics;May2007, Vol. 166 Issue 5, p405 

    Unlabelled: The aim of this study was to evaluate the incidence of paediatric multiple sclerosis (MS) and acute disseminated encephalomyelitis (ADEM) in Germany. In a prospective nationwide survey carried out between 1997 and 1999, all registered new cases of paediatric MS and ADEM...

  • Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis. Verbout, Norah; Yu, Xiaolin; Healy, Laura; Phillips, Kevin; Tucker, Erik; Gruber, András; McCarty, Owen; Offner, Halina // Metabolic Brain Disease;Feb2015, Vol. 30 Issue 1, p57 

    Multiple sclerosis (MS) is a neuroinflammatory disease characterized by demyelination and axonal damage of the central nervous system. The pathogenesis of MS has also been linked to vascular inflammation and local activation of the coagulation system, resulting in perivascular fibrin deposition....

  • Changes in corticospinal excitability evoked by common peroneal nerve stimulation depend on stimulation frequency. Mang, C. S.; Lagerquist, O.; Collins, D. F. // Experimental Brain Research;May2010, Vol. 203 Issue 1, p11 

    The afferent volley generated during neuromuscular electrical stimulation (NMES) can increase the excitability of the human corticospinal (CS) pathway. This study was designed to determine the effect of different frequencies of NMES applied over the common peroneal nerve on changes in CS...

  • Evoked potentials in monitoring multiple sclerosis. Leocani, L.; Medaglini, S.; Comi, G. // Neurological Sciences;Dec2000 Supplement 2, Vol. 21, pS889 

    The usefulness of evoked potentials (EPs) in the diagnosis of multiple sclerosis is limited by its relatively low sensitivity to subclinical lesions. However, they are still a good tool to assess the integrity of afferent and efferent pathways and to quantify the severity of white matter...

  • Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Smith, Terence; Groom, Anthony; Zhu, Bin; Turski, Lechoslaw // Nature Medicine;Jan2000, Vol. 6 Issue 1, p62 

    Multiple sclerosis is an immune-mediated disorder of the central nervous system leading to progressive decline of motor and sensory functions and permanent disability. The therapy of multiple sclerosis is only partially effective, despite anti-inflammatory, immunosuppresive and immunomodulatory...

  • HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. Shahbazi, M.; Ebadi, H.; Fathi, D.; Roshandel, D.; Mohamadhosseni, M.; Tahmasebi, A.; Shahbazi, S.; Zamani, M.; Rashidbaghan, A. // Multiple Sclerosis (13524585);Oct2010, Vol. 16 Issue 10, p1173 

    Background: The multifunctional cytokine interleukin-6 (IL-6) is involved in inflammatory processes in the central nervous system. It is well documented that amount of IL-6 is increased in serum, cerebrospinal fluid and central nervous system lesions of patients with multiple sclerosis. A single...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics